Article
APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrations
2026-05-12
Abstract excerpt
<title>Abstract</title> <p> Alzheimer’s disease (AD) plasma biomarkers are cost-effective tools to detect early stage amyloid pathology. We investigated how interactions between AD genetic risk (apolipoprotein E ( <italic>APOE</italic> ) ε4, AD polygenic risk score (excluding <italic>APOE;</italic> PRS <sub>AD</sub> )), age, and sex affected AD plasma biomarkers concentrations in a population-based cohort....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2099ee2-df2d-5f68-86de-e3dfef13bc42
- DOI
- 10.21203/rs.3.rs-8426026/v1
